BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28275973)

  • 1. Normal Neurological Development During Infancy Despite Massive Hyperammonemia in Early Treated NAGS Deficiency.
    Reigstad H; Woldseth B; Häberle J
    JIMD Rep; 2017; 37():45-47. PubMed ID: 28275973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favourable long-term outcome after immediate treatment of neonatal hyperammonemia due to N-acetylglutamate synthase deficiency.
    Gessler P; Buchal P; Schwenk HU; Wermuth B
    Eur J Pediatr; 2010 Feb; 169(2):197-9. PubMed ID: 19533169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early treatment of a child with NAGS deficiency using N-carbamyl glutamate results in a normal neurological outcome.
    Van Leynseele A; Jansen A; Goyens P; Martens G; Peeters S; Jonckheere A; De Meirleir L
    Eur J Pediatr; 2014 Dec; 173(12):1635-8. PubMed ID: 24233332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presentation and management of N-acetylglutamate synthase deficiency: a review of the literature.
    Kenneson A; Singh RH
    Orphanet J Rare Dis; 2020 Oct; 15(1):279. PubMed ID: 33036647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiency.
    Häberle J
    Ther Clin Risk Manag; 2011; 7():327-32. PubMed ID: 21941437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rare urea cycle disorder in a neonate: N-acetylglutamate synthetase deficiency.
    Olgac A; Kasapkara ÇS; Kilic M; Emine Derinkuyu B; Azapagasi E; Kesici S; Biberoğlu G; Ozyazici A; Karaca M; Haberle J
    Arch Argent Pediatr; 2020 Dec; 118(6):e545-e548. PubMed ID: 33231058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A trial with N-carbamylglutamate may not detect all patients with NAGS deficiency and neonatal onset.
    Nordenström A; Halldin M; Hallberg B; Alm J
    J Inherit Metab Dis; 2007 Jun; 30(3):400. PubMed ID: 17510757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of N-carbamoyl-L-glutamic acid for the treatment of inherited metabolic disorders.
    Chapel-Crespo CC; Diaz GA; Oishi K
    Expert Rev Endocrinol Metab; 2016; 11(6):467-473. PubMed ID: 30034506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene delivery corrects N-acetylglutamate synthase deficiency and enables insights in the physiological impact of L-arginine activation of N-acetylglutamate synthase.
    Sonaimuthu P; Senkevitch E; Haskins N; Uapinyoying P; McNutt M; Morizono H; Tuchman M; Caldovic L
    Sci Rep; 2021 Feb; 11(1):3580. PubMed ID: 33574402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effect of
    Sugiyama Y; Shimura M; Ogawa-Tominaga M; Ebihara T; Kinouchi Y; Isozaki K; Matsuhashi T; Tajika M; Fushimi T; Ichimoto K; Matsunaga A; Ishida T; Mizutani K; Tsuruoka T; Murayama K
    Mol Genet Metab Rep; 2020 Sep; 24():100622. PubMed ID: 32670798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of Carbamylglutamate impacts the nutritional management of patients with N-Acetylglutamate synthase deficiency.
    Singh RH; Bourdages MH; Kurtz A; MacLoed E; Norman C; Ratko S; van Calcar SC; Kenneson A
    Orphanet J Rare Dis; 2024 Apr; 19(1):168. PubMed ID: 38637895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations and polymorphisms in the human N-acetylglutamate synthase (NAGS) gene.
    Caldovic L; Morizono H; Tuchman M
    Hum Mutat; 2007 Aug; 28(8):754-9. PubMed ID: 17421020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial N-acetyl glutamate synthase deficiency presenting as postpartum hyperammonemia: Diagnosis and subsequent pregnancy management.
    Abou Haidar L; Pachnis P; Gotway GK; Ni M; DeBerardinis RJ; McNutt MC
    JIMD Rep; 2023 Nov; 64(6):403-409. PubMed ID: 37927481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal treatment of ornithine transcarbamylase deficiency.
    Wilnai Y; Blumenfeld YJ; Cusmano K; Hintz SR; Alcorn D; Benitz WE; Berquist WE; Bernstein JA; Castillo RO; Concepcion W; Cowan TM; Cox KL; Lyell DJ; Esquivel CO; Homeyer M; Hudgins L; Hurwitz M; Palma JP; Schelley S; Akula VP; Summar ML; Enns GM
    Mol Genet Metab; 2018 Mar; 123(3):297-300. PubMed ID: 29396029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetylglutamate synthase deficiency: Novel mutation associated with neonatal presentation and literature review of molecular and phenotypic spectra.
    Al Kaabi EH; El-Hattab AW
    Mol Genet Metab Rep; 2016 Sep; 8():94-8. PubMed ID: 27570737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early care of
    Peoc'h K; Damaj L; Pelletier R; Lefèvre C; Dubourg C; Denis MC; Bendavid C; Odent S; Moreau C
    Mol Genet Metab Rep; 2020 Mar; 22():100558. PubMed ID: 32021803
    [No Abstract]   [Full Text] [Related]  

  • 17. A novel biochemically salvageable animal model of hyperammonemia devoid of N-acetylglutamate synthase.
    Senkevitch E; Cabrera-Luque J; Morizono H; Caldovic L; Tuchman M
    Mol Genet Metab; 2012 Jun; 106(2):160-8. PubMed ID: 22503289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-carbamylglutamate markedly enhances ureagenesis in N-acetylglutamate deficiency and propionic acidemia as measured by isotopic incorporation and blood biomarkers.
    Tuchman M; Caldovic L; Daikhin Y; Horyn O; Nissim I; Nissim I; Korson M; Burton B; Yudkoff M
    Pediatr Res; 2008 Aug; 64(2):213-7. PubMed ID: 18414145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urea cycle disorders in Thai infants: a report of 5 cases.
    Wasant P; Srisomsap C; Liammongkolkul S; Svasti J
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S720-31. PubMed ID: 12403252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis.
    Brusilow SW; Danney M; Waber LJ; Batshaw M; Burton B; Levitsky L; Roth K; McKeethren C; Ward J
    N Engl J Med; 1984 Jun; 310(25):1630-4. PubMed ID: 6427608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.